Greetings from Mahidol University, Thailand!
Mahidol University has been living a long history for over 129 years since the establishment of “Siriraj Hospital” in 1888, then developed to a medical school in the next year. The name was bestowed upon by His Late Majesty King Bhumibol Adulyadej after His Royal Highness Prince Mahidol of Songkla. The University is recognized as a large higher education institution comprising academicians and professionals in every field, both in arts and sciences. Mahidol University had continued to progress in all aspects to stay relevant and conform to the rapidly changing world and society.
We are pleased to inform you that the application for Mahidol University Sawasdee Thailand Ph.D. Scholarship program is now open for Universitas Gadjah Mada students.
For more information please click this link
Eligibility
- S2 students or lecturer enrolled in Universitas Gadjah Mada or alumni
- Be proficient in English, proven by English Proficiency Certificate
Required Documents
- Curriculum Vitae
- Motivation Letter
- Letter of Enrollment from Faculty
- Letter of Nomination from Faculty (addressed to the Head of Office of International Affairs UGM)
- Study Plan
- Research Plan
- Official Academic Transcript
- Colored Copy of Passport
- English language proficiency (Min. Score of TOEFL – ITP=550, iBT 79 or IELTS 6.0)
- Confirmation Letter of Participation (download)
- Other requirement documents*
APPLICATION PROCEDURE
- Finish the online application to Mahidol University website directly in this link before 29th May 2021
- THE FINAL decision from Mahidol University
IMPORTANT NOTES:
- In case the faculty could not provide the letter of enrollment and nomination during this period, the official nomination through email from the faculty is acceptable. The official nomination could be delivered to head-oia@ugm.ac.id (cc to scholarship@ugm.ac.id).
- Application of outgoing mobility programs for fall semester in AY 2021/2022 will be processed but the implementation/execution will carefully consider the latest development of COVID-19 and government’s regulation.
Recent Comments